Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat

Neurotoxicology and Teratology

Volumn 32, Issue 6, 2010, Pages 640-647

  Rodríguez, Verónica Mireya ^a   Limón Pacheco, Jorge Humberto ^a   Carrizales, Leticia ^b   Mendoza Trejo, María Soledad ^a   Giordano, Magda ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Antioxidants; Arsenicals; Dopamine; Neurotoxicity; Striatum

Indexed keywords

ARSENIC; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRINKING WATER; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; GENE CONTROL; LOCOMOTION; LONG TERM EXPOSURE; MALE; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RODENT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; ANTIOXIDANTS; ARSENITES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NF-E2-RELATED FACTOR 2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEROTONIN; SODIUM COMPOUNDS; SUPEROXIDE DISMUTASE; THIOREDOXINS; TIME FACTORS; TISSUE DISTRIBUTION; WATER POLLUTANTS, CHEMICAL;

RATTUS; RODENTIA;

EID: 78049461924     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2010.07.005     Document Type: Article

References (52)

1. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 1999, 27:1405-1412.
2. Barchowsky A., Roussel R.R., Klei L.R., James P.E., Ganju N., Smith K.R., Dudek E.J. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 1999, 159:65-75.
3. Bardullas U., Limon-Pacheco J.H., Giordano M., Carrizales L., Mendoza-Trejo M.S., Rodriguez V.M. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol. Appl. Pharmacol. 2009, 239:169-177.
4. Bentivoglio M., Morelli M. The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in brain. Dopamine 2005, 62-77. Elsevier, Amsterdam. S.B. Dunnet, M. Bentivoglio, A. Björklund, T. Hökfelt (Eds.).
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
6. Chen Y., Parvez F., Gamble M., Islam T., Ahmed A., Argos M., Graziano J.H., Ahsan H. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol. Appl. Pharmacol. 2009, 239:184-192.
7. Chong S., Dill K., McGown E. The interaction of phenyldichloroarsine with erythrocytes. J. Biochem. Toxicol. 1989, 4:39-45.
8. Colombrita C., Calabrese V., Stella A.M., Mattei F., Alkon D.L., Scapagnini G. Regional rat brain distribution of heme oxygenase-1 and manganese superoxide dismutase mRNA: relevance of redox homeostasis in the aging processes. Exp. Biol. Med. (Maywood) 2003, 228:517-524.
9. Garcia-Chavez E., Santamaria A., Diaz-Barriga F., Mandeville P., Juarez B.I., Jimenez-Capdeville M.E. Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res. 2003, 976:82-89.
10. Garcia-Vargas G.G., Garcia-Rangel A., Aguilar-Romo M., Garcia-Salcedo J., del Razo L.M., Ostrosky-Wegman P., Cortinas de Nava C., Cebrian M.E. A pilot study on the urinary excretion of porphyrins in human populations chronically exposed to arsenic in Mexico. Hum. Exp. Toxicol. 1991, 10:189-193.
11. Hong Y., Piao F., Zhao Y., Li S., Wang Y., Liu P. Subchronic exposure to arsenic decreased Sdha expression in the brain of mice. Neurotoxicology 2009, 30:538-543.
12. Itoh T., Zhang Y.F., Murai S., Saito H., Nagahama H., Miyate H., Saito Y., Abe E. The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol. Lett. 1990, 54:345-353.
13. Jiang T., Huang Z., Chan J.Y., Zhang D.D. Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol. Appl. Pharmacol. 2009, 240:8-14.
14. Kruger K., Straub H., Hirner A.V., Hippler J., Binding N., Musshoff U. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats. Toxicol. Appl. Pharmacol. 2009, 236:115-123.
15. Kunikowska G., Jenner P. The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal ganglia. Biochem. Pharmacol. 2002, 63:1159-1164.
16. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 1994, 139:484-492.
17. Larouche A., Berube P., Sarret P., Grignon S. Subacute H2O2, but not poly(IC), upregulates dopamine D2 receptors in retinoic acid differentiated SH-SY5Y neuroblastoma. Synapse 2008, 62:70-73.
18. Limon-Pacheco J., Gonsebatt M.E. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat. Res. 2009, 674:137-147.
19. Lippoldt A., Padilla C.A., Gerst H., Andbjer B., Richter E., Holmgren A., Fuxe K. Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 1995, 15:6747-6756.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
21. Mejia J.J., Diaz-Barriga F., Calderon J., Rios C., Jimenez-Capdeville M.E. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol. Teratol. 1997, 19:489-497.
22. Miao L., St Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 2009, 47:344-356.
23. Nagaraja T.N., Desiraju T. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum. Exp. Toxicol. 1994, 13:353-356.
24. Niture S.K., Kaspar J.W., Shen J., Jaiswal A.K. Nrf2 signaling and cell survival. Toxicol. Appl. Pharmacol. 2010, 244:37-42.
25. Olsen C.M., Huang Y., Goodwin S., Ciobanu D.C., Lu L., Sutter T.R., Winder D.G. Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum. Physiol. Genomics 2008, 32:283-298.
26. Patenaude A., Murthy M.R., Mirault M.E. Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 2005, 62:1063-1080.
27. Pi J., Qu W., Reece J.M., Kumagai Y., Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell Res. 2003, 290:234-245.
28. Rios R., Zarazua S., Santoyo M.E., Sepulveda-Saavedra J., Romero-Diaz V., Jimenez V., Perez-Severiano F., Vidal-Cantu G., Delgado J.M., Jimenez-Capdeville M.E. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology 2009, 261:68-75.
29. Rodriguez V.M., Dufour L., Carrizales L., Diaz-Barriga F., Jimenez-Capdeville M.E. Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ. Health Perspect. 1998, 106:487-491.
30. Rodriguez V.M., Carrizales L., Jimenez-Capdeville M.E., Dufour L., Giordano M. The effects of sodium arsenite exposure on behavioral parameters in the rat. Brain Res. Bull. 2001, 55:301-308.
31. Rodriguez V.M., Carrizales L., Mendoza M.S., Fajardo O.R., Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 2002, 24:743-750.
32. Rodriguez V.M., Jimenez-Capdeville M.E., Giordano M. The effects of arsenic exposure on the nervous system. Toxicol. Lett. 2003, 145:1-18.
33. Rodriguez V.M., Thiruchelvam M., Cory-Slechta D.A. Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems. Environ. Health Perspect. 2005, 113:708-715.
34. Shavali S., Sens D.A. Synergistic neurotoxic effects of arsenic and dopamine in human dopaminergic neuroblastoma SH-SY5Y cells. Toxicol. Sci. 2008, 102:254-261.
35. Shi H., Shi X., Liu K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 2004, 255:67-78.
36. Shila S., Kokilavani V., Subathra M., Panneerselvam C. Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat. Toxicology 2005, 210:25-36.
37. Shiobara Y., Ogra Y., Suzuki K.T. Animal species difference in the uptake of dimethylarsinous acid (DMA(III)) by red blood cells. Chem. Res. Toxicol. 2001, 14:1446-1452.
38. Sloot W.N., Gramsbergen J.B. Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res. 1994, 657:124-132.
39. Takagi Y., Horikawa F., Nozaki K., Sugino T., Hashimoto N., Yodoi J. Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci. Lett. 1998, 251:25-28.
40. Takeuchi A., Miyaishi O., Kiuchi K., Isobe K. Cu/Zn- and Mn-superoxide dismutases are specifically up-regulated in neurons after focal brain injury. J. Neurobiol. 2000, 45:39-46.
41. Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 2000, 20:9207-9214.
42. Thomas D.J. Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 2007, 222:365-373.
43. Thomas D.J., Li J., Waters S.B., Xing W., Adair B.M., Drobna Z., Devesa V., Styblo M. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. (Maywood) 2007, 232:3-13.
44. Vahter M. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 1981, 25:286-293.
45. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
46. Wang Y. Differential effect of aging on synaptic plasticity in the ventral and dorsal striatum. Neurobiol. Learn. Mem. 2008, 89:70-75.
47. Wang X., Meng D., Chang Q., Pan J., Zhang Z., Chen G., Ke Z., Luo J., Shi X. Arsenic inhibits neurite outgrowth by inhibiting the LKB1-AMPK signaling pathway. Environ. Health Perspect. 2010, 118:627-634.
48. S. Xi, L. Guo, R. Qi, W. Sun, Y. Jin, G. Sun, Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain, J. Biochem. Mol. Toxicol. in press, http://doi:10.1002/jbt.20349.
49. Yadav R.S., Sankhwar M.L., Shukla R.K., Chandra R., Pant A.B., Islam F., Khanna V.K. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol. Appl. Pharmacol. 2009, 240:367-376.
50. Yamanaka K., Hoshino M., Okamoto M., Sawamura R., Hasegawa A., Okada S. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 1990, 168:58-64.
51. Zarazua S., Rios R., Delgado J.M., Santoyo M.E., Ortiz-Perez D., Jimenez-Capdeville M.E. Decreased arginine methylation and myelin alterations in arsenic exposed rats. Neurotoxicology 2009, 31:94-100.
52. Zheng W. Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc. Res. Technol. 2001, 52:89-103.